TY - JOUR
T1 - Monitoring Live Mycobacteria in Real-Time Using a Microfluidic Acoustic-Raman Platform
AU - Chen, Mingzhou
AU - Baron, Vincent
AU - Hammarström, Björn
AU - Hammond, Robert J H
AU - Glynne-Jones, Peter
AU - Gillespie, Stephen H
AU - Dholakia, Kishan
N1 - © 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2024
Y1 - 2024
N2 - Tuberculosis (TB) is the most common cause of death from an infectious disease. Although treatment has been available for more than 70 years, it still takes too long and many patients default risking relapse and the emergence of resistance. It is known that lipid-rich, phenotypically antibiotic-tolerant, bacteria are more resistant to antibiotics and may be responsible for relapse necessitating extended therapy. Using a microfluidic system that acoustically traps live mycobacteria, M. smegmatis, a model organism for M. tuberculosis we can perform optical analysis in the form of wavelength-modulated Raman spectroscopy (WMRS) on the trapped organisms. This system can allow observations of the mycobacteria for up to 8 h. By adding antibiotics, it is possible to study the effect of antibiotics in real-time by comparing the Raman fingerprints in comparison to the unstressed condition. This microfluidic platform may be used to study any microorganism and to dynamically monitor its response to many conditions including antibiotic stress, and changes in the growth media. This opens the possibility of understanding better the stimuli that trigger the lipid-rich downregulated and phenotypically antibiotic-resistant cell state.
AB - Tuberculosis (TB) is the most common cause of death from an infectious disease. Although treatment has been available for more than 70 years, it still takes too long and many patients default risking relapse and the emergence of resistance. It is known that lipid-rich, phenotypically antibiotic-tolerant, bacteria are more resistant to antibiotics and may be responsible for relapse necessitating extended therapy. Using a microfluidic system that acoustically traps live mycobacteria, M. smegmatis, a model organism for M. tuberculosis we can perform optical analysis in the form of wavelength-modulated Raman spectroscopy (WMRS) on the trapped organisms. This system can allow observations of the mycobacteria for up to 8 h. By adding antibiotics, it is possible to study the effect of antibiotics in real-time by comparing the Raman fingerprints in comparison to the unstressed condition. This microfluidic platform may be used to study any microorganism and to dynamically monitor its response to many conditions including antibiotic stress, and changes in the growth media. This opens the possibility of understanding better the stimuli that trigger the lipid-rich downregulated and phenotypically antibiotic-resistant cell state.
KW - Spectrum Analysis, Raman/methods
KW - Mycobacterium smegmatis/drug effects
KW - Microfluidics/methods
KW - Anti-Bacterial Agents/pharmacology
KW - Acoustics/instrumentation
KW - Lab-On-A-Chip Devices
KW - Microfluidic Analytical Techniques/instrumentation
KW - Humans
U2 - 10.1007/978-1-0716-3981-8_11
DO - 10.1007/978-1-0716-3981-8_11
M3 - Article
C2 - 38949705
SN - 1064-3745
VL - 2833
SP - 109
EP - 119
JO - Methods in Molecular Biology
JF - Methods in Molecular Biology
ER -